Almirall - PharmaKB

Almirall

Almirall, S.A. is a Spanish pharmaceutical company, with headquarters in Barcelona, founded in 1943.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Aczone	Dapsone	2016-02-24	2033	Aids-related opportunistic infections , Dermatitis herpetiformis , Lepromatous leprosy , Relapsing polychondritis
Altabax	Retapamulin	2007-04-12	2024-2027	Impetigo , Staphylococcal skin infections , Bacterial infections
Azelex	Azelaic acid	1995-09-13	2024-2029	Acne vulgaris , Rosacea
Cordran	Flurandrenolide	1982-01-01		Facial dermatoses, Foot dermatoses, Hand dermatoses, Inflammation, Leg dermatoses
Ilumetri	Tildrakizumab	2018-09-17		Psoriasis
Klisyri	Tirbanibulin	2020-12-14	2025-2038	Actinic keratosis
Seysara	Sarecycline	2018-10-01	2028-2033	Acne vulgaris
Skilarence	Dimethylfumarate	2017-06-23	2028-2035	Multiple sclerosis, Psoriasis, Relapsing-remitting multiple sclerosis
Solage	Mequinol, Tretinoin	1999-12-10	2023-2038	Acne vulgaris, Facial dermatoses, Hyperpigmentation, Promyelocytic leukemia acute
Vaniqa	Eflornithine	2001-03-19		Hirsutism, African trypanosomiasis, Hypertrichosis, Protozoan infections
Veltin	Clindamycin, Tretinoin	2010-07-16	2024-2040	Acne vulgaris, Actinomycetales infections, Bacterial infections, Bacterial vaginosis, Bacteroides infections, Pneumocystis pneumonia, Staphylococcal infections, Streptococcal infections, Toxoplasmosis
Verdeso	Desonide	2006-09-19	2025-2027	Facial dermatoses, Foot dermatoses, Hand dermatoses, Inflammation, Leg dermatoses, Scalp dermatoses